Rituximab impairs B‐cell response but not T‐cell response to COVID ‐19 vaccine in auto‐immune diseases-Reference-Cited by-同舟云学术

Rituximab impairs B‐cell response but not T‐cell response to COVID ‐19 vaccine in auto‐immune diseases

Published:2021-12-28 Issue: Volume: Page:
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Bitoun Samuel¹²^ORCID,Henry Julien¹,Desjardins Delphine²,Vauloup‐Fellous Christelle³,Dib Nicolas¹,Belkhir Rakiba¹,Mouna Lina³,Joly Candie²,Bitu Marie²,Ly Bineta²,Pascaud Juliette²,Seror Raphaèle¹²^ORCID,Roque Afonso Anne‐Marie³,Le Grand Roger²,Mariette Xavier¹²

Affiliation:

1. Hôpital Bicêtre, Assistance Publique‐Hôpitaux de Paris, FHU CARE, Rheumatology department

2. Université Paris‐Saclay, Inserm UMR 1184, CEA, Center for Immunology of Viral, Auto‐immune, Hematological and Bacterial Diseases (IMVA‐HB/IDMIT), Fontenay‐aux‐Roses & Le Kremlin‐Bicêtre France

3. Université Paris Saclay, INSERM U1193, AP‐HP, Hôpital Paul Brousse, Virology department

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42058

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment;Frontiers in Immunology;2024-09-04

2. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

3. Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness;Lupus;2024-08-12

4. Long-term use of rituximab increases T cell count in MS patients;Frontiers in Immunology;2024-07-17

5. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25